Skip to content

Dako Diagnostics, Ltd.

United KingdomFDA applicant, unverified

Devices
6

What Dako Diagnostics, Ltd. makes

Dako Diagnostics produces rapid diagnostic tests for respiratory pathogens, including assays for rotavirus, influenza virus groups, parainfluenza virus types 1–3, and respiratory screen panels. The IMAGEN platform supports visual detection of these viral targets in clinical samples, while IDEIA reagents are used for chlamydia testing modifications.

These devices are classified as Class I under FDA regulations and are authorised via the 510(k) pathway. The company is based in the United States, with its products listed in the FDA’s 510(k) registry.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue6

Newest first, rows 1-6 of 6

Frequently asked questions

How many devices does Dako Diagnostics, Ltd. have in the registry?

The registry currently lists 6 devices for Dako Diagnostics, Ltd.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Dako Diagnostics, Ltd.'s devices?

Among its 6 most recently registered devices, Dako Diagnostics, Ltd. has devices listed in FDA 510(k) (6 devices).

What risk classes do Dako Diagnostics, Ltd.'s devices fall under?

Among its 6 most recently registered devices, the classes recorded for Dako Diagnostics, Ltd.'s devices are Class I. Each device page shows its own class and authorisation.

What are the newest devices from Dako Diagnostics, Ltd. in the registry?

The most recently registered devices listed for Dako Diagnostics, Ltd. include IMAGEN, IDEIA(TM) ROTAVIRUS, IMAGEARAINFLUENZA VIRUS GROUP (TYPES 1, 2 AND 3) TEST AND IMAGEN PARAINFLUENZA VIRUS TEST TYPES 1, 2 AND 3 and IMAGEN RESPIRATORY SCREEN.

Generated automatically from registry data and not verified by a human reviewer.